Abstract
Positron emission tomography (PET) has the unique ability to image bodily functions, such as blood flow, oxygen use, and glucose metabolism. PET imaging in combination with computerized tomography (CT) offers a high sensitivity scan for metabolic activity with precise anatomical localization. PET/CT with the glucose analog 18F-fluorodeoxyglucose (FDG) has become an essential tool for the work-up of patients with cancer for clinical practice. F-18-FDG PET/CT provides valuable information about differential diagnosis, staging and therapy response of oncologic disease. Lung cancer remains the most common cause of death from malignant disease in the world both in women and in men. In this article, the role of F-18-FDG PET and F-18-FDG PET/CT in lung cancers have been reviewed
Keywords
References
- Minna JD, Schiller JH. Neoplasm of the lung. In Harrison's Principles of Internal Medicine ,17th ed (Eds Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL et al):551–562. New York, McGraw-Hill, 2008.
- Suzuki K, Nagai K, Yoshida J, Moriyama E, Nishimura M, Takahashi K et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 1999; 67:927–32.
- Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978; 32:303-13. Wahbah M, Boroumand N, Castro C, El-Zeky F, Eltorky M. Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol. 2007; 11:89-96. Zeren EH. Akciger kanserine patolojik yaklasım. In Akciger Kanseri (Eds Hastürk S, Yüksel M): 29– İstanbul, Bilmedya Grup, 2000.
- Mudun A. Türkiye’de PET görüntülemenin durumu. Turk J Nucl Med. 2008; 17:1-9.
Abstract
Pozitron emisyon tomografi (PET), kan akımı, oksijen tüketimi ve glukoz metabolizması gibi vücut fonksiyonlarını görüntülemede çok değerlidir. PET görüntüleme, bilgisayarlı tomografi (BT) ile birleştirildiğinde doğru anatomik lokalizasyonla birlikte metabolik aktivitenin yüksek duyarlılıkla tesbit edilmesini sağlar. Glukoz analoğu F-18- FDG ile yapılan PET/BT, kanserli hastaların görüntülenmesinde en önemli tetkiklerden biri olmuştur. F-18-FDG PET/BT, onkolojik hastalıkların ayırıcı tanısında, evrelemede ve tedavi cevabını değerlendirmede değerli bilgiler sağlar. Akciğer kanseri dünyada kadın ve erkeklerde en sık ölüme neden olan malign hastalıktır. Bu makalede, F-18-FDG PET ve F-18-FDG PET/BT'nin akciğer kanserlerindeki rolü gözden geçirilecektir.
Keywords
References
- Minna JD, Schiller JH. Neoplasm of the lung. In Harrison's Principles of Internal Medicine ,17th ed (Eds Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL et al):551–562. New York, McGraw-Hill, 2008.
- Suzuki K, Nagai K, Yoshida J, Moriyama E, Nishimura M, Takahashi K et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg. 1999; 67:927–32.
- Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978; 32:303-13. Wahbah M, Boroumand N, Castro C, El-Zeky F, Eltorky M. Changing trends in the distribution of the histologic types of lung cancer: a review of 4,439 cases. Ann Diagn Pathol. 2007; 11:89-96. Zeren EH. Akciger kanserine patolojik yaklasım. In Akciger Kanseri (Eds Hastürk S, Yüksel M): 29– İstanbul, Bilmedya Grup, 2000.
- Mudun A. Türkiye’de PET görüntülemenin durumu. Turk J Nucl Med. 2008; 17:1-9.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Review |
| Authors | |
| Publication Date | December 1, 2013 |
| Published in Issue | Year 2013 Volume: 22 Issue: 4 |
